Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Inflamm Bowel Dis. 2011 Jan;17(1):471-8. doi: 10.1002/ibd.21417. Epub 2010 Aug 19.
Crohn's disease (CD) is a chronic, progressive, destructive disease. Numerous intestinal and extraintestinal complications and manifestations can occur during its clinical course. This literature review summarizes our current knowledge of the long-term complications, extraintestinal complications, and mortality in CD in adults as reported in population-based studies that include long-term follow-up results.
A literature search of English and non-English language publications listed in the electronic databases of Medline (source PubMed, 1935 to July, 2009).
The relative risk of incident fractures is increased in CD patients by ≈30%-40%. These patients have also have a 3-fold increased risk of deep venous thrombosis and pulmonary embolism. A variety of extraintestinal manifestations (primary sclerosing cholangitis, ankylosing spondylitis, iritis/uveitis, pyoderma gangrenosum, erythema nodosum) and diseases (asthma, bronchitis, pericarditis, psoriasis, rheumatoid arthritis, and multiple sclerosis) are associated with CD. The risks of colorectal and small bowel cancers relative to the general population are 1.4-1.9 and 21.1-27.1, respectively. A slightly increased risk of lymphoma, irrespective of medication use, has been reported in a recent meta-analysis of population-based studies. Overall mortality is slightly increased in CD, with a standardized mortality ratio of 1.4.
CD is frequently associated with disease complications and extraintestinal conditions. Whether the impact of changing treatment paradigms with increased use of immunosuppressives and biologic agents can reduce disease complications and associated conditions is unknown.
克罗恩病(CD)是一种慢性、进行性、破坏性疾病。在其临床过程中可能会出现许多肠道和肠道外并发症和表现。这篇文献综述总结了我们目前对人群研究中报告的成人 CD 的长期并发症、肠道外并发症和死亡率的认识,这些研究包括长期随访结果。
在电子数据库 Medline(来源 PubMed,1935 年至 2009 年 7 月)中对英文和非英文文献进行了检索。
CD 患者的骨折发生率风险增加约 30%-40%。这些患者深静脉血栓形成和肺栓塞的风险也增加了 3 倍。多种肠道外表现(原发性硬化性胆管炎、强直性脊柱炎、虹膜炎/葡萄膜炎、坏疽性脓皮病、结节性红斑)和疾病(哮喘、支气管炎、心包炎、银屑病、类风湿关节炎、多发性硬化症)与 CD 相关。与普通人群相比,结直肠癌和小肠癌的风险分别为 1.4-1.9 和 21.1-27.1。最近的一项人群研究荟萃分析报告,淋巴瘤的风险无论是否使用药物都略有增加。CD 的总死亡率略有增加,标准化死亡率比为 1.4。
CD 常伴有疾病并发症和肠道外疾病。改变治疗模式以增加使用免疫抑制剂和生物制剂是否可以减少疾病并发症和相关疾病尚不清楚。